Category

Blastoma

mRNA Vaccine Shrinks Deadly Childhood Cancer Tumors by 70% Blastoma

mRNA Vaccine Shrinks Deadly Childhood Cancer Tumors by 70%

A new preclinical study suggests an experimental mRNA vaccine could help the immune system fight neuroblastoma, one of the deadliest childhood cancers. Credit: Stock An experimental mRNA vaccine delayed neuroblastoma growth and sharply reduced tumor size in preclinical models. The success of mRNA vaccines during the COVID-19 pandemic sparked interest…
bubmag
June 29, 2026
TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control Blastoma

TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control

Proceedings of the National Academy of Sciences, Volume 123, Issue 25, June 2026. SignificanceICAM-1/LFA-1 interactions enhance immune cell avidity, stabilizing immune synapses and improving cytotoxicity in solid tumors. The IFNγ signaling pathway was found to be essential for ICAM1 upregulation. Here, we revealed in glioblastoma that ...Read More
bubmag
June 18, 2026
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026 Blastoma

Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026

Published : , ,   Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patients A manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patients SEONGNAM and SEOUL, South Korea, June 15, 2026 /PRNewswire/ --…
bubmag
June 15, 2026